





















We provide FDA‑approved medication, including buprenorphine. Brand-name Suboxone combines buprenorphine and naloxone to reduce cravings and withdrawal symptoms and help deter misuse. Our clinicians follow established clinical guidelines and schedule regular check-ins to keep your treatment on track.
Patients are matched with a dedicated care team focused on reducing their cravings and managing their symptoms. If something comes up between visits, you can request support without waiting weeks for your next appointment. Providers are available seven days a week.
At Ophelia, opioid use disorder is all we treat. This specialization means we understand how factors like mental health, stress, and relapse risk affect treatment. Our providers also know how to manage cravings and withdrawal and adjust your plan if necessary. You get the right dose, at the right frequency, right from the privacy of your home.


Common medications used to treat OUD are buprenorphine, methadone, and naltrexone. All three are approved by the Food and Drug Administration (FDA), but only buprenorphine and methadone are associated with significant reductions in opioid-related deaths.
Our clinicians most commonly prescribe buprenorphine/naloxone (brand name Suboxone). Buprenorphine reduces cravings and withdrawal symptoms and is associated with overdose reductions of 50% or more, while naloxone helps deter misuse. When taken as part of a comprehensive OUD treatment plan, Suboxone supports long-term maintenance and lowers misuse.
Your care team will help you determine which medicine is covered by your insurance, tolerable to take, and effective at managing your symptoms.
Yes. Research shows that OUD treatment delivered through secure video visits offers similar or better retention when compared to in-person care.
One review of 135 buprenorphine-treated patients showed comparable retention rates for telehealth and in-person care. Telehealth was also shown to decrease costs by reducing transportation and indirect expenses. Another analysis of Medicaid data found that people who started buprenorphine after a virtual visit were more likely to stay in treatment longer than those who started medication after an in-person appointment.
Most new patients can meet with an Ophelia clinician within one to three days. Treatment starts after a full clinical evaluation to make sure medication is appropriate and timed correctly.
Yes, current federal regulations allow qualified providers to prescribe buprenorphine online to individuals with OUD. This approach is supported by leading addiction medicine professional groups, as telehealth visits have been shown to reduce opioid overdose.
No, opioid addiction treatment through Ophelia is 100% virtual. We’re adamant about privacy, and we never require you to visit a physical clinic. Frankly, it’s nobody’s business if you’re receiving treatment.
Ophelia accepts Medicaid, Medicare, and most commercial insurance plans. Coverage varies by plan, but many patients pay less than $10 per month for care. Our team confirms your benefits before your first visit.

Suboxone®, a brand name of the generic buprenorphine/naloxone, is the gold standard of care for opioid addiction treatment.

There are several types of MAT for opioid use disorder. One treatment is buprenorphine. Here’s everything you need to know.

Medication-assisted treatment is tailored to the specific needs of individuals with opioid use disorder.

Ophelia conducted research to help you understand how buprenorphine helps the body overcome opioid addiction.
